Edition:
United Kingdom

Insider Trading: Onconova Therapeutics Inc (ONTX.OQ)

ONTX.OQ on NASDAQ Stock Exchange Capital Market

2.94USD
4:45pm GMT
Change (% chg)

$-0.11 (-3.61%)
Prev Close
$3.05
Open
$3.01
Day's High
$3.02
Day's Low
$2.94
Volume
2,772
Avg. Vol
24,682
52-wk High
$39.00
52-wk Low
$2.94

All Insider Trades
Trading Date Name Title Type Shares Traded Price
29 Aug 2018

Hoffman (Michael B)

Director Sell 29,999 $0.45
28 Aug 2018

Hoffman (Michael B)

Director Sell 20,000 $0.44
28 Aug 2018

Hoffman (Michael B)

Director Sell 30,000 $0.46
27 Aug 2018

Hoffman (Michael B)

Director Sell 20,000 $0.45
29 May 2018

Bienen (Henry S)

Director Buy 10,000 $0.38
27 Apr 2018

Stover (Jack E)

Director Buy 47,100 $0.00
27 Apr 2018

683 Capital Management L L C

Beneficial Owner of More than 10% Class Buy 11,838,235 $0.43
27 Apr 2018

Marino (James J)

Director Buy 58,900 $0.00
27 Apr 2018

Tyndall Capital Partners, L.P.

Beneficial Owner of More than 10% Class Buy 10,147,058 $0.43
27 Apr 2018

Hoffman (Michael B)

Director Buy 2,211,765 $0.00
27 Apr 2018

Reddy (E Premkumar)

Director Buy 282,350 $0.00
8 Feb 2018

Marino (James J)

Director Buy 50,000 $0.00
8 Feb 2018

683 Capital Management L L C

Beneficial Owner of More than 10% Class Buy 200,000 $1.04
8 Feb 2018

Tyndall Capital Partners, L.P.

Beneficial Owner of More than 10% Class Buy 1,100,000 $1.01
26 Apr 2017

Guerin Mark Patrick

Chief Financial Officer Buy 1,429 $2.10
26 Apr 2017

Bienen (Henry S)

Director Buy 3,810 $2.10
26 Apr 2017

Kumar (Ramesh)

Chief Executive Officer Buy 23,810 $2.10
26 Apr 2017

Reddy (E Premkumar)

Director Buy 119,048 $2.10
26 Apr 2017

Marino (James J)

Director Buy 11,906 $2.10
21 Apr 2017

Tyndall Capital Partners, L.P.

Beneficial Owner of More than 10% Class Buy 476,190 $2.10

Institutional Holders

% Shares Owned: 54.09%
# of Holders: 24
Total Shares Held: 3,068,970
3 Mo. Net Change: 89,874
# New Positions: 4
# Closed Positions: 13
# Increased Positions: 11
# Reduced Positions: 19
# Net Buyers: -8

Officers & Directors

Name Age Since Current Position

Michael Hoffman

67 2006 Chairman of the Board

Steven Fruchtman

2018 President

Ramesh Kumar

2018 Chief Executive Officer, Director

Mark Guerin

47 2016 Chief Financial Officer

Manoj Maniar

52 2005 Senior Vice President - Product Development

Abraham Oler

2018 Vice President, Corporate Development and General Counsel

Henry Bienen

76 2009 Director

Jerome Groopman

63 2013 Director

Viren Mehta

65 2004 Director

E. Premkumar Reddy

71 1999 Director

Jack Stover

64 2016 Director

Anne VanLent

68 2013 Director

James Marino

68 2015 Independent Director